Government of Brazil   Report issue

Government Phase 1 Phase 2 Phase 3 Phase 4
Founded: Brasília Brazil (1889)

Organization Overview

First Clinical Trial
2005
NCT00701246
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Brazilian National Institute of Hormones and Women's Health | Ceará Health Secretariat - SESA | Central Laboratory of Public Health of Ceara - LACEN-CE | Central Laboratory of Public Health of Ceará - Lacen-CE | CNPq Universal | Financiadora de Estudos e Projetos | INCA Brazil | INCA - Instituto Nacional de Cancer | INCA- Instituto Nacional de Câncer | InCor (HC-FMUSP) | Instituto Nacional de Cancer | Instituto Nacional de Cancer, Brazil | Instituto Nacional de Câncer Brazil | Instituto Nacional do Câncer - INCA - HCIII | Military Fire Department of the Federal District | Ministry of Health, Brazil | Ministry of Science and Technology, Brazil | Municipal Health Secretary - SMS-Fortaleza | Rio Grande do Sul State Health Department - SES/RS | Secretaria Municipal de Saúde de Bauru | Secretaria Municipal de Saúde de Guarulhos | Secretaria Nacional de Políticas sobre Drogas (SENAD)

Active Ingredients

Drugs in Phase 4 Trials (14)

amphotericin b (fungizone) (2 trials)

atorvastatin (lipitor) (1 trial)

cabozantinib (cometriq) (1 trial)

clofazimine (lamprene) (1 trial)

dapsone (aczone) (1 trial)

deoxycholic acid (kybella) (1 trial)

efavirenz (sustiva) (2 trials)

lopinavir (Kaletra) (1 trial)

meglumine (2 trials)

methylglucamine antimoniate (1 trial)

palonosetron (aloxi) (1 trial)

rifampin (1 trial)

ritonavir (Norvir) (1 trial)

yellow fever vaccine 17d strain (1 trial)

Drugs in Phase 3 Trials (44)

acetylcysteine (mucomyst) (1 trial)

allopurinol (zyloprim) (1 trial)

amiloride (midamor) (2 trials)

amlodipine (norvasc) (1 trial)

artesunate (1 trial)

biperiden (akineton) (1 trial)

bone marrow derived mesenchymal stem cells (1 trial)

bromhexine (1 trial)

butantan (1 trial)

capecitabine (xeloda) (1 trial)

carboplatin (paraplatin) (2 trials)

chloroquine (1 trial)

chlorthalidone (Hygroton) (2 trials)

cyclophosphamide (cytoxan) (3 trials)

dihydroartemisinin (1 trial)

docetaxel (taxotere) (2 trials)

doxorubicin (Doxil) (3 trials)

ertapenem (invanz) (1 trial)

escitalopram (lexapro) (1 trial)

fluorouracil (efudex) (2 trials)

folfirinox (1 trial)

inactivated influenza vaccine (2 trials)

lactobacillus reuteri (1 trial)

lactobacillus rhamnosus (1 trial)

lamivudine (epivir) (1 trial)

lidocaine (xylocaine) (2 trials)

losartan (cozaar) (1 trial)

mefloquine (lariam) (1 trial)

miconazole (monistat) (1 trial)

paclitaxel (taxol) (2 trials)

pemetrexed (alimta) (1 trial)

piperaquine (1 trial)

primaquine (2 trials)

propolis (1 trial)

raltegravir (isentress) (1 trial)

rosuvastatin (crestor) (1 trial)

sargramostim (leukine) (1 trial)

selenium (1 trial)

stem cells (1 trial)

tenecteplase (tnkase) (2 trials)

tenofovir (viread) (2 trials)

trichilia catigua (1 trial)

valsartan (diovan) (1 trial)

vitamin c (3 trials)

Drugs in Phase 2 Trials (25)

acetylsalicylic acid (aspirin) (1 trial)

alectinib (alecensa) (1 trial)

aminolevulinic acid (levulan) (1 trial)

anastrozole (arimidex) (1 trial)

autologous mononuclear stem cell (1 trial)

bacille calmette-guerin (1 trial)

cisplatin (platinol) (2 trials)

erlotinib (tarceva) (1 trial)

exemestane (aromasin) (1 trial)

forodesine (1 trial)

fulvestrant (faslodex) (1 trial)

gemcitabine (gemzar) (1 trial)

hydroxypropyl-beta-cyclodextrin (1 trial)

ingenol mebutate (picato) (1 trial)

insulin human (humulin) (1 trial)

letrozole (femara) (1 trial)

megestrol (megace) (1 trial)

morphine (1 trial)

nitazoxanide (Alinia) (2 trials)

nivolumab (opdivo) (1 trial)

oat bran (1 trial)

pembrolizumab (keytruda) (1 trial)

tamoxifen (nolvadex) (1 trial)

trimetazidine (1 trial)

zoledronic acid (zometa) (1 trial)

Drugs in Phase 1 Trials (7)

allogeneic adipose derived mesenchymal stem cell (1 trial)

cardiamp (1 trial)

copaiba (1 trial)

gla-se (1 trial)

magnesium sulfate (Tis-U-Sol) (1 trial)

sitagliptin (januvia) (1 trial)

sm14 vaccine (1 trial)

Drugs in Other Trials (10)

amiodarone (cordarone) (1 trial)

coartem (1 trial)

emtricitabine (emtriva) (1 trial)

ferrous sulfate (1 trial)

folic acid (1 trial)

lumefantrine (Coartem) (1 trial)

nicotine (nicorette) (1 trial)

sofosbuvir (sovaldi) (1 trial)

velpatasvir (Epclusa) (1 trial)

water (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 4)

Adenocarcinoma (Phase 2)

Angina Pectoris (Phase 3)

Atherosclerosis (Phase 2)

Breast Diseases (Phase 2)

Breast Neoplasms (Phase 3)

Bronchopulmonary Dysplasia (Phase 3)

Candidiasis (Phase 3)

Candidiasis, Oral (Phase 3)

Carcinoma, Neuroendocrine (Phase 4)

Carcinoma, Non-Small-Cell Lung (Phase 3)

Cardiomyopathies (Phase 3)

Cardiomyopathy, Dilated (Phase 3)

Cardiovascular Diseases (Phase 3)

Chagas Cardiomyopathy (Phase 3)

Chagas Disease (Phase 3)

Cheilitis (Phase 2)

Coronavirus Infections (Phase 2)

Depression (Phase 3)

Dyslipidemias (Phase 2)

Fever (Phase 4)

Fibrosis (Phase 2)

Glomerulosclerosis, Focal Segmental (Phase 1)

Head and Neck Neoplasms (Phase 1)

Heart Diseases (Phase 3)

Hepatitis (Phase 2)

Hepatitis A (Phase 1)

Hepatitis C, Chronic (Phase 1)

Hepatitis, Chronic (Phase 2)

HIV Infections (Phase 4)

Hypercholesterolemia (Phase 2)

Hypertension (Phase 3)

Infections (Phase 3)

Influenza, Human (Phase 3)

Kidney Diseases (Phase 1)

Leishmaniasis (Phase 4)

Leishmaniasis, Cutaneous (Phase 4)

Leishmaniasis, Visceral (Phase 4)

Leprosy (Phase 4)

Leukemia (Phase 2)

Leukemia, Lymphoid (Phase 2)

Leukomalacia, Periventricular (Phase 3)

Leukoplakia (Phase 2)

Liver Cirrhosis (Phase 2)

Liver Diseases (Phase 2)

Lymphoma (Phase 2)

Malaria (Phase 3)

Malaria, Falciparum (Phase 3)

Malaria, Vivax (Phase 3)

Nausea (Phase 4)

Neoplasms (Phase 3)

Neoplasms by Site (Phase 2)

Pneumonia (Phase 2)

Pneumonia, Viral (Phase 2)

Postoperative Nausea and Vomiting (Phase 4)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Prehypertension (Phase 3)

Premature Birth (Phase 3)

Pressure Ulcer (Phase 2)

Rectal Neoplasms (Phase 3)

Renal Insufficiency, Chronic (Phase 1)

Respiratory Distress Syndrome (Phase 3)

Respiratory Distress Syndrome, Newborn (Phase 3)

Schistosomiasis (Phase 1)

Severe Acute Respiratory Syndrome (Phase 2)

Stomatitis (Phase 3)

Stomatitis, Denture (Phase 3)

Syndrome (Phase 4)

Thyroid Diseases (Phase 4)

Thyroid Neoplasms (Phase 4)

Triple Negative Breast Neoplasms (Phase 2)

Tuberculosis (Phase 4)

Ulcer (Phase 2)

Urinary Tract Infections (Phase 3)

Uterine Cervical Neoplasms (Phase 2)

Vaginal Diseases (Phase 3)

Vaginosis, Bacterial (Phase 3)

Vomiting (Phase 4)

Yellow Fever (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 70
  • # of Trial APIs: 100